SEI Investments’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,826
| Closed | -$475K | – | 2820 |
|
|
2025
Q2 | $475K | Sell |
4,826
-324
| -6% | -$30.7K | ﹤0.01% | 2207 |
|
|
2025
Q1 | $477K | Buy |
5,150
+1,601
| +45% | +$148K | ﹤0.01% | 2161 |
|
|
2024
Q4 | $322K | Sell |
3,549
-3,636
| -51% | -$334K | ﹤0.01% | 2336 |
|
|
2024
Q3 | $694K | Sell |
7,185
-2,304
| -24% | -$225K | ﹤0.01% | 2074 |
|
|
2024
Q2 | $871K | Sell |
9,489
-1,940
| -17% | -$180K | ﹤0.01% | 1961 |
|
|
2024
Q1 | $1.05M | Sell |
11,429
-531
| -4% | -$49.8K | ﹤0.01% | 1866 |
|
|
2023
Q4 | $1.14M | Buy |
11,960
+467
| +4% | +$43.6K | ﹤0.01% | 1833 |
|
|
2023
Q3 | $1.07M | Sell |
11,493
-105,691
| -90% | -$9.77M | ﹤0.01% | 1858 |
|
|
2023
Q2 | $10.7M | Buy |
117,184
+52,894
| +82% | +$4.34M | 0.02% | 835 |
|
|
2023
Q1 | $4.73M | Buy |
64,290
+13,255
| +26% | +$1.15M | 0.01% | 1213 |
|
|
2022
Q4 | $4.26M | Sell |
51,035
-56,501
| -53% | -$5.09M | 0.01% | 1128 |
|
|
2022
Q3 | $10.4M | Sell |
107,536
-11,452
| -10% | -$1.37M | 0.02% | 746 |
|
|
2022
Q2 | $12.5M | Buy |
118,988
+73,637
| +162% | +$9.41M | 0.03% | 671 |
|
|
2022
Q1 | $7.85M | Buy |
45,351
+3,931
| +9% | +$587K | 0.02% | 875 |
|
|
2021
Q4 | $6.61M | Buy |
41,420
+13,892
| +50% | +$2.23M | 0.01% | 990 |
|
|
2021
Q3 | $4.04M | Sell |
27,528
-12,570
| -31% | -$2.61M | 0.01% | 1198 |
|
|
2021
Q2 | $9.74M | Sell |
40,098
-6,511
| -14% | -$1.71M | 0.02% | 746 |
|
|
2021
Q1 | $12.5M | Sell |
46,609
-9,614
| -17% | -$2.71M | 0.03% | 571 |
|
|
2020
Q4 | $16.5M | Buy |
56,223
+2,056
| +4% | +$527K | 0.04% | 420 |
|
|
2020
Q3 | $12.8M | Sell |
54,167
-9,616
| -15% | -$2.19M | 0.04% | 450 |
|
|
2020
Q2 | $12.6M | Sell |
63,783
-50,478
| -44% | -$9.41M | 0.04% | 450 |
|
|
2020
Q1 | $20.9M | Sell |
114,261
-1,260
| -1% | -$224K | 0.08% | 250 |
|
|
2019
Q4 | $19.3M | Buy |
115,521
+3,944
| +4% | +$587K | 0.06% | 326 |
|
|
2019
Q3 | $14.7M | Sell |
111,577
-13,491
| -11% | -$1.76M | 0.04% | 435 |
|
|
2019
Q2 | $15.2M | Buy |
125,068
+6,500
| +5% | +$771K | 0.05% | 398 |
|
|
2019
Q1 | $14.6M | Sell |
118,568
-12,759
| -10% | -$1.6M | 0.05% | 402 |
|
|
2018
Q4 | $16.3M | Buy |
131,327
+7,986
| +6% | +$941K | 0.06% | 361 |
|
|
2018
Q3 | $15.4M | Sell |
123,341
-241
| -0.2% | -$26.6K | 0.06% | 362 |
|
|
2018
Q2 | $10.6M | Buy |
123,582
+109,246
| +762% | +$8.02M | 0.04% | 553 |
|
|
2018
Q1 | $865K | Sell |
14,336
-74,492
| -84% | -$4.24M | ﹤0.01% | 1464 |
|
|
2017
Q4 | $4.71M | Sell |
88,828
-2,878
| -3% | -$152K | 0.02% | 940 |
|
|
2017
Q3 | $5.13M | Sell |
91,706
-8,532
| -9% | -$451K | 0.02% | 875 |
|
|
2017
Q2 | $6.3M | Buy |
100,238
+23,922
| +31% | +$1.39M | 0.03% | 740 |
|
|
2017
Q1 | $3.9M | Buy |
76,316
+10,794
| +16% | +$515K | 0.02% | 907 |
|
|
2016
Q4 | $2.79M | Buy |
65,522
+10,747
| +20% | +$457K | 0.01% | 1025 |
|
|
2016
Q3 | $2.6M | Buy |
54,775
+995
| +2% | +$49.7K | 0.01% | 989 |
|
|
2016
Q2 | $2.71M | Buy |
53,780
+1,159
| +2% | +$58.5K | 0.02% | 896 |
|
|
2016
Q1 | $2.54M | Buy |
52,621
+14,172
| +37% | +$547K | 0.02% | 873 |
|
|
2015
Q4 | $1.51M | Buy |
38,449
+38,447
| +1,922,350% | +$1.54M | 0.01% | 1098 |
|
|
2015
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 2481 |
|
|
2015
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 2262 |
|
|
2015
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 2244 |
|
|
2014
Q4 | $0 | Buy |
+2
| New | +$49 | ﹤0.01% | 2200 |
|
Other funds holding AMED
IA
MCI
HNB
SEI Investments's AMED Position: Q3 2025 in Review
SEI Investments sold out of Amedisys (AMED) in Q3 2025, closing a stake of 4,826 shares — an estimated $475K sold.
SEI Investments first reported a position in AMED in Q4 2014 and held it in 43 quarters. The position peaked at $20.9M in Q1 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- SEI Investments reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- SEI Investments sold 4,826 Amedisys shares in Q3 2025, an estimated $475K.
- SEI Investments first reported a position in Amedisys in Q4 2014 and held it in 43 quarters.
- SEI Investments's Amedisys position peaked at $20.9M in Q1 2020.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on SEI Investments's 13F filing for Q3 2025, filed 13 Nov 2025.